Stock Analiz

Baird Medical Investment Holdings Ltd BDMD

Medical/Dental Instruments · data as of November 13, 2026

$0.09Market cap $4M
Open the interactive analysis →

Baird Medical Investment Holdings Ltd (BDMD) is a healthcare company listed in the US with a market value of about $4M. In fiscal year 2025 it had revenue of $23M and net income of -$27M, a net margin of -121.0%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of 13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 68% below the current price.

About Baird Medical Investment Holdings

Baird Medical Investment Holdings is listed in the US and classified in medical/dental instruments. Revenue went from $35M in 2022 to $23M in 2025, a decline of about 13.7% a year. It was profitable in 3 of the last 4 years in our data. It spends 89% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth1/5
Track record1/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Strong R&D investment or growth above 20%
  • 5-year average ROIC above 12%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.2
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-36.2%
Shareholder yield0.0%
Intrinsic value vs. price−68%

Growth and quality

Revenue growth (1 yr)-39.1%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-4.5%
ROIC (5-yr avg.)13.3%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 4 years

Fiscal year2025202420232022
Revenue$23M$37M$31M$35M
Net income-$27M$12M$11M$13M
Free cash flow-$1M-$9M-$4M-$5M
EPS (diluted)$-0.64$0.29$0.25$0.30
Net margin-121.0%33.6%33.5%35.8%
ROIC-50.3%30.8%26.2%46.5%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Baird Medical Investment Holdings stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 68% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Baird Medical Investment Holdings pay a dividend?

Not currently.

Is Baird Medical Investment Holdings a good stock to buy?

We do not give buy or sell advice. Baird Medical Investment Holdings scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.